Across cardiovascular system subgroups, we found an overall decrease of 8.8% (p<0.01) in ARB prescriptions by the end of the study period associated with an 8% (p=0.05) marginally significant cost decrease.
← all excerpts
Impact of the COVID-19 pandemic on prescription drug use and costs in British Columbia: a retrospective interrupted time series study.
1
—
—